SCHEMBL7623640

SCHEMBL7623640

ICc1ccccc1-c1ccncc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNA5 P22460 3/20 0.50
KCNH2 Q12809 2/20 0.50
NOTUM Q6P988 1/20 0.44
CYP11B1 P15538 1/20 0.42
CYP11B2 P19099 1/20 0.42
DPP4 P27487 1/20 0.42
AURKA O14965 1/20 0.42
CDK1 P06493 1/20 0.42
LYN P07948 1/20 0.42
PIM1 P11309 1/20 0.42
FGFR1 P11362 1/20 0.42
PRKACA P17612 1/20 0.42
RPS6KB1 P23443 1/20 0.42
CDK2 P24941 1/20 0.42
MARK3 P27448 1/20 0.42
AKT1 P31749 1/20 0.42
GSK3B P49841 1/20 0.42
RPS6KA3 P51812 1/20 0.42
PRKCZ Q05513 1/20 0.42
PRKCD Q05655 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6968676 0.82 DPP4 (0.60) KCNA5KCNH2CYP11B1CYP11B2DPP4
SCHEMBL477401 0.81 KCNA5 (0.51) KCNA5KCNH2NOTUMCYP11B1CYP11B2
Methane SCHEMBL28852242 0.79 KCNA5 (0.50) KCNA5KCNH2NOTUMCYP11B1CYP11B2
SCHEMBL1129835 0.79 KCNA5 (0.50) KCNA5KCNH2NOTUMCYP11B1CYP11B2
SCHEMBL3288611 0.79 DPP4 (0.69) KCNA5KCNH2NOTUMCYP11B1CYP11B2
SCHEMBL9289991 0.79 KCNA5 (0.50) KCNA5KCNH2NOTUMCYP11B1CYP11B2
SCHEMBL21480329 0.79 KCNA5 (0.59) KCNA5KCNH2CYP11B1CYP11B2MAPT
SCHEMBL28966771 0.78 KCNA5 (0.49) KCNA5KCNH2NOTUMCYP11B1CYP11B2
Hydrochloric Acid SCHEMBL14856328 0.78 KCNH2 (0.49) KCNA5KCNH2NOTUMCYP11B1CYP11B2
SCHEMBL29712508 0.77 DPP4 (0.41) DPP4AKT1MAPTLMNAHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180200346-A1 ALBUMIN FUSION PROTEINS ALBUMEDIX A/S (DK) 2018-07-19 US disclosed
EP-1259526-A2 NUCLEIC ACIDS, PROTEINS, AND ANTIBODIES Human Genome Sciences, Inc. (US) 2002-11-27 EP disclosed
WO-2001055318-A2 NUCLEIC ACIDS, PROTEINS, AND ANTIBODIES HUMAN GENOME SCIENCES, INC. (US) 2001-08-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180200346-A1 ALBUMIN FUSION PROTEINS ALB, FABP1, HDGF KCNA5 4470/4885KCNH2 4825/4885NOTUM 3959/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.